TMCnet News

Chronic Pain Therapeutics Pipeline Review, H2 2015 - Research and Markets
[February 03, 2016]

Chronic Pain Therapeutics Pipeline Review, H2 2015 - Research and Markets


Research and Markets (http://www.researchandmarkets.com/research/nzwtj5/chronic_pain) has announced the addition of the "Chronic Pain - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Chronic Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Pain and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Chronic Pain Overview
  3. Therapeutics Development
  4. Pipeline Products for Chroni Pain - Overview
  5. Pipeline Products for Chronic Pain - Comparative Analysis
  6. Chronic Pain - Therapeutics under Development by Companies
  7. Chronic Pain - Therapeutics under Investigation by Universities/Institutes
  8. Chronic Pain - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Chronic Pain - Products under Development by Companies
  13. Chronic Pain - Products under Investigation by Universities/Institutes
  14. Chronic Pain - Companies Involved in Therapeutics Development



Companies Featured (Partial List)

  • AbbVie Inc.
  • Acadia Pharmaceuticals Inc.
  • Adynxx, Inc.
  • Allergan Plc
  • Amorsa Therapeutics Inc.
  • arGEN-X BV
  • AskAt Inc.
  • Astellas Pharma Inc.
  • Astraea Therapeutics, LLC
  • AstraZeneca Plc
  • BioDelivery Sciences International, Inc.
  • Bionomics Limited
  • Cara Therapeutics, Inc.
  • Charleston Laboratories, Inc.
  • ChironWells GmbH
  • Collegium Pharmaceutical, Inc.
  • CoLucid Pharmaceuticals, Inc.
  • Convergence (News - Alert) Pharmaceuticals Ltd.
  • Creabilis SA
  • Crinetics Pharmaceuticals, Inc.
  • Cyclenium Pharma, Inc.
  • Cytogel Pharma, LLC
  • Daewoong Pharmaceutical Co., Ltd.
  • Daiichi Sankyo Company, Limited
  • Dompe Farmaceutici S.p.A.
  • Echo Pharmaceuticals B.V.
  • Egalet Corporation
  • Eli Lilly and Company
  • Elite Pharmaceuticals, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Grunenthal GmbH
  • Heron Therapeutics, Inc.
  • INSYS Therapeutics, Inc.
  • Johnson & Johnson
  • Kareus Therapeutics, SA

For more information visit http://www.researchandmarkets.com/research/nzwtj5/chronic_pain



[ Back To TMCnet.com's Homepage ]